| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |